AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DOXAZOSINE

15 registrations across 3 African markets— 12 active

Markets with DOXAZOSINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
CARDULAR PP URO
Comprimé à libération prolongée / 4 mg
🇹🇳TunisiaPFIZER OFG GERMANY GmbHexpiredJan 2022
CARDOX
Comprimé sécable / 4 MG
🇹🇳TunisiaIBN AL BAYTARexpiredApr 2007
CARDOX
Comprimé / 1 mg
🇹🇳TunisiaIBN AL BAYTARexpiredApr 2007
URADOX 2 MG
COMPRIME
🇲🇦Moroccoactive
URADOX 2 MG
COMPRIME
🇲🇦Moroccoactive
CARDULAR
comprimé / 4 mg
🇸🇳SenegalPFIZER GMBHactive
CARDURA
COMPRIME
🇲🇦Moroccoactive
CARDURA
COMPRIME
🇲🇦Moroccoactive
ZOXAN LP 4MG
COMPRIME LP
🇲🇦Moroccoactive
ZOXAN LP 4MG
COMPRIME LP
🇲🇦Moroccoactive
CARDURA
COMPRIME
🇲🇦Moroccoactive
URADOX 2MG
COMPRIME
🇲🇦Moroccoactive
URADOX 2MG
COMPRIME
🇲🇦Moroccoactive
CARDOX
comprimé / 1 mg
🇸🇳SenegalIBN AL BAYTARactive
CARDOX
comprimé / 4 mg
🇸🇳SenegalIBN AL BAYTARactive

DOXAZOSINE in Africa — Regulatory Overview

DOXAZOSINE is registered across 3 African markets with 15 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Senegal, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.

Of the 15 registrations, 12 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.